Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.61 USD | +4.28% |
|
+8.72% | -15.00% |
05-20 | Top Premarket Decliners | MT |
05-14 | ESSA Pharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.00% | 249M | |
+22.15% | 46.56B | |
+45.21% | 41.67B | |
-2.37% | 41.16B | |
+33.84% | 32.4B | |
+20.42% | 28.18B | |
-6.35% | 28.1B | |
+48.83% | 14.52B | |
+45.00% | 13.74B | |
+0.06% | 12.17B |
- Stock Market
- Equities
- EPIX Stock
- News ESSA Pharma Inc.
- ESSA Pharma : Oppenheimer Adjusts ESSA Pharma PT to $20 From $9, Maintains Outperform Rating